Subscribe to RSS
DOI: 10.1055/a-2106-4732
Incidence of Stroke in People With Diabetes Compared to Those Without Diabetes: A Systematic Review
Funding Information German Federal Ministry of Health — ZMV I 1–2516DIA001Abstract
Background One of the goals of the St. Vincent Declaration was to reduce serious complications of diabetes, including strokes. However, it remains uncertain whether this goal has been achieved. Study aim: To evaluate the incidence of stroke in the diabetic population and its differences regarding sex, ethnicity, age, and region, to compare the incidence rate in people with and without diabetes, and to investigate time trends.
Materials and methods A systematic review was conducted according to the guidelines for meta-analysis of observational studies in epidemiology (the MOOSE group) and the PRISMA group guidelines.
Results Nineteen of the 6.470 studies retrieved were included in the analysis. The incidence of stroke in the population with diabetes ranged from 238 per 100,000 person-years in Germany in 2014 to 1191 during the 1990s in the United Kingdom. The relative risk comparing people with diabetes to those without diabetes varied between 1.0 and 2.84 for total stroke, 1.0 and 3.7 for ischemic stroke, and 0.68 and 1.6 for hemorrhagic stroke. Differences between fatal and non-fatal stroke were significant, depending on the time period and the population. We found decreasing time trends in people with diabetes and stable incidence rates of stroke over time in people without diabetes.
Conclusion The considerable differences between results can partly be explained by differences in study designs, statistical methods, definitions of stroke, and methods used to identify patients with diabetes. The lack of evidence arising from these differences ought to be rectified by new studies.
Publication History
Received: 10 January 2023
Received: 21 April 2023
Accepted: 24 April 2023
Accepted Manuscript online:
06 June 2023
Article published online:
17 July 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Saeedi P, Petersohn I, Salpea P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843 DOI: 10.1016/j.diabres.2019.107843.
- 2 World Health Organization. Global report on diabetes 2020; ISBN 978 924 1565257; http://www.who.int
- 3 GBD Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18: 439-458 DOI: 10.1016/s1474-4422(19)30034-1.
- 4 Icks A, Claessen H. Incidence and relative risk of stroke in the diabetic and the non-diabetic population between 1998 and 2014: A community-based stroke register. PLoS One 2017; 12: e0188306 DOI: 10.1371/journal.pone.0188306.
- 5 Rautio A, Eliasson M, Stegmayr B. Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects: Findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003. Stroke 2008; 39: 3137-3144 DOI: 10.1161/strokeaha.107.504100.
- 6 Munoz-Rivas N, Mendez-Bailon M, Hernandez-Barrera V. et al. Time trends in ischemic stroke among type 2 diabetic and non-diabetic patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012). PloS One 2015; 10: e0145535 DOI: 10.1371/journal.pone.0145535.
- 7 Read SH, McAllister DA, Colhoun HM. et al. Incident ischaemic stroke and type 2 diabetes: Trends in incidence and case fatality in Scotland 2004-2013. Diabet Medicine 2018; 35: 99-106 DOI: 10.1111/dme.13528.
- 8 [Anonymous] Diabetes care and research in Europe: The Saint Vincent declaration. Diabet Med 1990; 7: 360
- 9 Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 2014; 383: 1973-1980 DOI: 10.1016/s0140-6736(14)60040-4.
- 10 Wang J, Wen X, Li W. et al. Risk factors for stroke in the Chinese population: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2017; 26: 509-517 DOI: 10.1016/j.jstrokecerebrovasdis.2016.12.002.
- 11 Ariesen MJ, Claus SP, Rinkel GJ. et al. Risk factors for intracerebral hemorrhage in the general population: A systematic review. Stroke 2003; 34: 2060-2065 DOI: 10.1161/01.STR.0000080678.09344.8D.
- 12 Yang W, Kong F, Liu M. et al. Systematic review of risk factors for progressive ischemic stroke. Neural Regen Res 2011; 6: 346-352
- 13 Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (London, England) 2014; 47: 1973-1980
- 14 Sarwar N, Gao P, Seshasai SR. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222 DOI: 10.1016/s0140-6736(10)60484-9.
- 15 Bragg F, Li L, Yang L. et al. Risks and population burden of cardiovascular diseases associated with diabetes in China: A prospective study of 0.5 million adults. PLoS Medicine 2016; 13: e1002026 DOI: 10.1371/journal.pmed.1002026.
- 16 Chen R, Ovbiagele B, Feng W. Diabetes and stroke: Epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci 2016; 351: 380-386 DOI: 10.1016/j.amjms.2016.01.011.
- 17 Icks A, Scheer M, Genz J. et al. Stroke in the diabetic and non-diabetic population in Germany: Relative and attributable risks, 2005-2007. J Diabetes Complications 2011; 25: 90-96 DOI: 10.1016/j.jdiacomp.2010.05.002.
- 18 Moher D, Shamseer L, Clarke M. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1 DOI: 10.1186/2046-4053-4-1.
- 19 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine 2009; 6: e1000097 DOI: 10.1371/journal.pmed.1000097.
- 20 Kvitkina T, Narres M, Claessen H. et al. Incidence of stroke in the diabetic compared with the non-diabetic population: A systematic review protocol. Diabetes Metab Res Rev 2020; e3310 DOI: 10.1002/dmrr.3311.
- 21 Royle P, Bain L, Waugh N. Systematic reviews of epidemiology in diabetes: Finding the evidence. BMC Medical Res Methodol 2005; 5: 2 DOI: 10.1186/1471-2288-5-2.
- 22 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012 DOI: 10.1001/jama.283.15.2008.
- 23 Narres M, Claessen H, Droste S. et al. The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: A systematic review. PloS One 2016; 11: e0147329 DOI: 10.1371/journal.pone.0147329.
- 24 Narres M, Kvitkina T, Claessen H. et al. Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review. PloS One 2017; 12: e0182081 DOI: 10.1371/journal.pone.0182081.
- 25 Shamliyan T, Ansari MT, Raman G. et al. Development and implementation of the standards for evaluating and reporting epidemiologic studies on chronic disease incidence or prevalence. Am J Public Health Res 2013; 1: 183-190
- 26 Scottish Intercollegiate Guidelines Network (SIGN). Methodology Checklist 1: Systematic Reviews and Meta-analyses. In: Critical Appraisal Notes and Checklists; 2018
- 27 Cochrane Consumers and Communication Review Group. Guide for Review Authors on assessing study quality. In: Study Quality Guide; 2013
- 28 Mulnier HE, Seaman HE, Raleigh VS. et al. Risk of stroke in people with type 2 diabetes in the UK: A study using the General Practice Research Database. Diabetologia 2006; 49: 2859-2865 DOI: 10.1007/s00125-006-0493-z.
- 29 Icks A, Claessen H, Kvitkina T. et al. Incidence and relative risk of stroke in the diabetic and the non-diabetic population between 1998 and 2014: A community-based stroke register. PLoS One 2017; 12: e0188306 DOI: 10.1371/journal.pone.0188306.
- 30 Schableger K, Inreiter L. Incidence of stroke in the diabetic and non-diabetic population in Upper Austria (2008-2012) and. Austrian J Stat 2015; 44: 69-83 DOI: 10.17713/ajs.v44i3.38.
- 31 Kiss Z, Rokszin G, Abonyi-Toth Z. et al. Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: A nationwide population study from Hungary. Cardiovasc 2018; 17: 107 DOI: 10.1186/s12933-018-0751-7.
- 32 Price AJ, Wright FL, Green J. et al. Differences in risk factors for 3 types of stroke: UK prospective study and meta-analyses. Neurology 2018; 90: e298-e306 DOI: 10.1212/WNL.0000000000004856.
- 33 Lopez-De-andres A, Jimenez-Garcia R, Zamorano-Leon JJ. et al. Sex-related disparities in the incidence and outcomes of ischemic stroke among type 2 diabetes patients. A matched-pair analysis using the spanish national hospital discharge database for years 2016-2018. Int J Environ Res Public Health 2021; 18: 3659 DOI: 10.3390/ijerph18073659.
- 34 Peters SAE, Carcel C, Millett ERC. et al. Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study. Neurology 2020; 95: e2715-e2726 DOI: 10.1212/WNL.0000000000010982.
- 35 Folsom AR, Rasmussen ML, Chambless LE. et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care 1999; 22: 1077-1083
- 36 Hu FB, Stampfer MJ, Haffner SM. et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002; 25: 1129-1134
- 37 Janghorbani M, Jones RB, Gilmour WH. et al. A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycaemics. J Clin Epidemiol 1994; 47: 397-405
- 38 Khoury JC, Kleindorfer D, Alwell K. et al. Diabetes mellitus: A risk factor for ischemic stroke in a large biracial population. Stroke 2013; 44: 1500-1504 DOI: 10.1161/STROKEAHA.113.001318.
- 39 Malla G, Long DL, Judd SE. et al. Does the association of diabetes with stroke risk differ by age, race, and sex? Results From the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Diabetes Care 2019; 42: 1966-1972 DOI: 10.2337/dc19-0442.
- 40 Liao CC, Shih CC, Yeh CC. et al. Impact of diabetes on stroke risk and outcomes: Two nationwide retrospective cohort studies. Medicine 2015; 94: e2282 DOI: 10.1097/MD.0000000000002282.
- 41 Kim JH, Jeon J, Kim J. Lower risk of subarachnoid haemorrhage in diabetes: A nationwide population-based cohort study. Stroke Vasc 2021; 01: 01 DOI: 10.1136/svn-2020-000601.
- 42 Davis WA, Gregg EW, Davis TME. Temporal trends in cardiovascular complications in people with or without type 2 diabetes: The Fremantle Diabetes Study. J Clin Endocrinol Metab 2020; 105: 01 DOI: 10.1210/clinem/dgaa215.
- 43 Kiss Z, Nagy L, Reiber I. et al. Persistence with statin therapy in Hungary. Arch Med Sci 2013; 9: 409-417 DOI: 10.5114/aoms.2013.35327.
- 44 Tsai CF, Anderson N, Thomas B. et al. Comparing risk factor profiles between intracerebral hemorrhage and ischemic stroke in Chinese and white populations: Systematic review and meta-analysis. PloS One 2016; 11: e0151743 DOI: 10.1371/journal.pone.0151743.
- 45 Luitse MJ, Biessels GJ, Rutten GE. et al. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11: 261-271 DOI: 10.1016/s1474-4422(12)70005-4.
- 46 Broderick JP, Diringer MN, Hill MD. et al. Determinants of intracerebral hemorrhage growth: An exploratory analysis. Stroke 2007; 38: 1072-1075 DOI: 10.1161/01.str.0000258078.35316.30.
- 47 Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 2003; 61: 1351-1356 DOI: 10.1212/01.wnl.0000094326.30791.2d.
- 48 Snarska KK, Bachórzewska-Gajewska H, Kapica-Topczewska K. et al. Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke. Arch Med Sci 2017; 13: 100-108 DOI: 10.5114/aoms.2016.61009.
- 49 Gregg EW, Li Y, Wang J. et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014; 370: 1514-1523 DOI: 10.1056/NEJMoa1310799.
- 50 Thiele I, Linseisen J, Heier M. et al. Time trends in stroke incidence and in prevalence of risk factors in Southern Germany, 1989 to 2008/09. Sci Rep 2018; 8: 11981 DOI: 10.1038/s41598-018-30350-8.
- 51 Benatru I, Rouaud O, Durier J. et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke 2006; 37: 1674-1679 DOI: 10.1161/01.STR.0000226979.56456.a8.
- 52 Intiso D, Stampatore P, Zarrelli MM. et al. Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995. Eur J Neurol 2003; 10: 559-565 DOI: 10.1046/j.1468-1331.2003.00648.x.
- 53 Feigin VL, Lawes CM, Bennett DA. et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009; 8: 355-369 DOI: 10.1016/s1474-4422(09)70025-0.
- 54 Feigin VL, Mensah GA, Norrving B. et al. Atlas of the global burden of stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology 2015; 45: 230-236 DOI: 10.1159/000441106.
- 55 Feigin VL, Forouzanfar MH, Krishnamurthi R. et al. Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet 2014; 383: 245-254 DOI: 10.1016/s0140-6736(13)61953-4.
- 56 de Ferranti SD, de Boer IH, Fonseca V. et al. Type 1 diabetes mellitus and cardiovascular disease: A scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 2014; 37: 2843-2863 DOI: 10.2337/dc14-1720.
- 57 Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 2014; 7: 587-591 DOI: 10.2147/dmso.s67400.
- 58 Putaala J, Liebkind R, Gordin D. et al. Diabetes mellitus and ischemic stroke in the young: Clinical features and long-term prognosis. Neurology 2011; 76: 1831-1837 DOI: 10.1212/WNL.0b013e31821cccc2.
- 59 Shah AD, Langenberg C, Rapsomaniki E. et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1·9 million people. Lancet Diabetes Endocrinol 2015; 3: 105-113 DOI: 10.1016/s2213-8587(14)70219-0.
- 60 Hu G, Sarti C, Jousilahti P. et al. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005; 36: 2538-2543 DOI: 10.1161/01.str.0000190894.30964.75.
- 61 Larsson SC, Wallin A, Håkansson N. et al. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol 2018; 262: 66-70 DOI: 10.1016/j.ijcard.2018.03.099.
- 62 Hägg S, Thorn LM, Forsblom CM. et al. Different risk factor profiles for ischemic and hemorrhagic stroke in type 1 diabetes mellitus. Stroke 2014; 45: 2558-2562 DOI: 10.1161/strokeaha.114.005724.
- 63 Regensteiner JG, Golden S, Huebschmann AG. et al. Sex differences in the cardiovascular consequences of diabetes mellitus: A scientific statement from the American Heart Association. Circulation 2015; 132: 2424-2447 DOI: 10.1161/cir.0000000000000343.
- 64 Zhao W, Katzmarzyk PT, Horswell R. et al. Sex differences in the risk of stroke and HbA(1c) among diabetic patients. Diabetologia 2014; 57: 918-926 DOI: 10.1007/s00125-014-3190-3.
- 65 Dufouil C, Beiser A, McLure LA. et al. Revised Framingham stroke risk profile to reflect temporal trends. Circulation 2017; 135: 1145-1159 DOI: 10.1161/circulationaha.115.021275.
- 66 Anyanwagu U, Mamza J, Donnelly R. et al. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: A large UK cohort study. Cardiovasc Diabetol 2017; 16: 107 DOI: 10.1186/s12933-017-0587-6.
- 67 Huxley RR, Bell EJ, Lutsey PL. et al. A comparative analysis of risk factors for stroke in blacks and whites: The Atherosclerosis Risk in Communities study. Ethn Health 2014; 19: 601-616 DOI: 10.1080/13557858.2013.857765.